<!--
  questions-and-answers-section-b.html
  Data for the mock exam - Specifically for Section B: Narcotics/Controlled Drugs.
-->

<div id="exam-data-source-section-b" style="display: none;">

    <div class="question-item" data-id="jp_b_001">
        <p class="question-text">According to the Narcotic Control Regulations, which two of the following are characteristics of a "Straight Narcotic"?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">It can be a single narcotic ingredient or multiple narcotic ingredients compounded together.</div>
            <div class="choice-option" data-correct="true">It CANNOT be prescribed verbally; a written prescription is required.</div>
            <div class="choice-option">It typically contains one narcotic and two or more other non-narcotic medicinal ingredients.</div>
            <div class="choice-option">It can always be transferred between pharmacies once, similar to targeted substances.</div>
            <div class="choice-option">It includes preparations like Tylenol #3.</div>
            <div class="choice-option">It can be compounded with one of the "5 Narcotics" (Hydrocodone, Morphine, Oxycodone, Pentazocine, Diacetylmorphine) and one non-narcotic ingredient.</div>
            <div class="choice-option">It is classified as NAPRA Schedule II.</div>
            <div class="choice-option">Refills are permitted if authorized by the prescriber in writing.</div>
            <div class="choice-option">It is primarily for parenteral use only.</div>
            <div class="choice-option">Advertising for straight narcotics is permitted if it only mentions the drug's name and price.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_002">
        <p class="question-text">Which two of the following accurately describe "Verbal Prescription Narcotics" in Ontario?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">They are narcotic combinations containing only one narcotic drug and two or more other medicinal (non-narcotic) ingredients.</div>
            <div class="choice-option" data-correct="true">They CANNOT contain any of the "5 Narcotics" (Hydrocodone, Morphine, Oxycodone, Pentazocine, Diacetylmorphine) and must not be for parenteral use.</div>
            <div class="choice-option">Tylenol #1 is an example of a Verbal Prescription Narcotic.</div>
            <div class="choice-option">Prescriptions for Verbal Prescription Narcotics can be refilled if authorized by the prescriber.</div>
            <div class="choice-option">These prescriptions can be transferred multiple times between pharmacies.</div>
            <div class="choice-option">A pharmacy technician can independently receive and document a verbal prescription for these narcotics.</div>
            <div class="choice-option">They are classified as NAPRA Schedule III drugs.</div>
            <div class="choice-option">Examples include injectable morphine preparations.</div>
            <div class="choice-option">They must always be hidden from public view in the pharmacy.</div>
            <div class="choice-option">A written follow-up prescription must be received within 72 hours for a verbal order.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_003">
        <p class="question-text">Regarding "Exempted Codeine Preparations" in Ontario, select two correct statements.</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">They can contain up to a maximum of 8mg of codeine per tablet/capsule or 20mg of codeine per 30mL of liquid, along with at least two other non-narcotic medicinal ingredients.</div>
            <div class="choice-option" data-correct="true">They are classified as NAPRA Schedule II and cannot be displayed visibly in the pharmacy; patients must request them.</div>
            <div class="choice-option">They require a written prescription from a physician or dentist.</div>
            <div class="choice-option">Pharmacists must always supply these preparations when requested, regardless of suspected misuse.</div>
            <div class="choice-option">These preparations can be sold in any retail store, similar to Schedule U drugs.</div>
            <div class="choice-option">The warning label "Contains codeine and should not be administered to children except on advice of a physician or dentist" is optional.</div>
            <div class="choice-option">Tylenol #3 is an example of an Exempted Codeine Preparation.</div>
            <div class="choice-option">These products can be freely advertised to the public.</div>
            <div class="choice-option">They are also known as "Straight Narcotics."</div>
            <div class="choice-option">There are no restrictions on the quantity that can be sold to a single patient at one time.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_004">
        <p class="question-text">Which two of the "5 Narcotics" listed in the PDF (Hydrocodone, Morphine, Oxycodone, Pentazocine, Diacetylmorphine) render a narcotic combination ineligible to be prescribed as a "Verbal Prescription Narcotic"?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Oxycodone</div>
            <div class="choice-option" data-correct="true">Hydrocodone</div>
            <div class="choice-option">Codeine (when not exceeding limits for exempted preps)</div>
            <div class="choice-option">Meperidine</div>
            <div class="choice-option">Fentanyl</div>
            <div class="choice-option">Buprenorphine</div>
            <div class="choice-option">Hydromorphone</div>
            <div class="choice-option">Methadone (when used in combinations outside MMT)</div>
            <div class="choice-option">Tramadol</div>
            <div class="choice-option">Tapentadol</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_005">
        <p class="question-text">What are two mandatory requirements for any prescription for a narcotic or controlled drug in Ontario?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The name and address of the patient.</div>
            <div class="choice-option" data-correct="true">The name, strength (if applicable), quantity, and form of the drug.</div>
            <div class="choice-option">The patient's diagnosis or the medical reason for the prescription.</div>
            <div class="choice-option">The specific lot number of the drug to be dispensed.</div>
            <div class="choice-option">The patient's preferred pharmacy for dispensing.</div>
            <div class="choice-option">The signature of both the prescriber and a witness.</div>
            <div class="choice-option">The date the prescription must be filled by.</div>
            <div class="choice-option">The prescriber's home phone number in case of emergencies.</div>
            <div class="choice-option">The time of day the prescription was written.</div>
            <div class="choice-option">A statement confirming the patient has no known allergies to the prescribed drug.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_006">
        <p class="question-text">Regarding refills for narcotics, controlled drugs, and benzodiazepines/targeted substances in Ontario, which two statements are accurate?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Refills are NOT permitted for any narcotic prescriptions (though part-fills are allowed).</div>
            <div class="choice-option" data-correct="true">Prescriptions for benzodiazepines and targeted substances are valid for refills for a maximum of 1 year from the date the prescription was originally written by the prescriber.</div>
            <div class="choice-option">Controlled Drugs, Part I, can be refilled if the original prescription was verbal, provided the prescriber verbally authorizes the number of refills.</div>
            <div class="choice-option">All controlled drugs (Parts I, II, and III) can be refilled indefinitely as long as the patient requires the medication.</div>
            <div class="choice-option">If a prescriber indicates "PRN refills" on a controlled drug prescription, the pharmacist can refill it as needed for up to 18 months.</div>
            <div class="choice-option">Narcotic prescriptions can be refilled up to 5 times within 6 months.</div>
            <div class="choice-option">For benzodiazepines, the 1-year validity for refills starts from the date the prescription was first filled, not when it was written.</div>
            <div class="choice-option">Verbal prescriptions for Controlled Drugs Part II can be refilled if the prescriber faxes authorization.</div>
            <div class="choice-option">There are no restrictions on the number of refills for Controlled Drugs Part III preparations.</div>
            <div class="choice-option">If a narcotic prescription specifies "M: 200, dispense 50 Q20D", this is considered a refill authorization.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_007">
        <p class="question-text">What are two key rules concerning the transfer of prescriptions for narcotics, controlled drugs, and benzodiazepines/targeted substances in Ontario?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Transfers are NOT permitted for any narcotic prescriptions, including part-fills and logged prescriptions.</div>
            <div class="choice-option" data-correct="true">Prescriptions for benzodiazepines and targeted substances may be transferred ONCE ONLY between pharmacies.</div>
            <div class="choice-option">Controlled Drugs, Part I, can be transferred multiple times as long as valid refills remain.</div>
            <div class="choice-option">If a benzodiazepine prescription is transferred from Pharmacy A to Pharmacy B, Pharmacy B can then transfer any remaining refills to Pharmacy C.</div>
            <div class="choice-option">All prescription transfers must be authorized verbally by the original prescribing practitioner.</div>
            <div class="choice-option">Logged prescriptions for controlled drugs (Part II) can be transferred if the patient provides written consent.</div>
            <div class="choice-option">There are no restrictions on transferring prescriptions for Controlled Drugs Part III.</div>
            <div class="choice-option">A pharmacy can transfer a narcotic prescription if it is for an emergency supply to another pharmacy.</div>
            <div class="choice-option">Transfers of targeted substances are only permitted within the same pharmacy chain.</div>
            <div class="choice-option">If a controlled drug prescription has part-fills authorized, each part-fill can be transferred independently to different pharmacies.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_008">
        <p class="question-text">Regarding record-keeping for sales of narcotics and controlled drugs, which two requirements must Ontario pharmacies adhere to?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Sales records must be kept for all Narcotics and Controlled Drugs Part I.</div>
            <div class="choice-option" data-correct="true">Sales records can be maintained in a Narcotic and Controlled Drug Register or in a computer system from which a printout can be readily obtained on request or is available on the premises.</div>
            <div class="choice-option">Sales records are not required for Controlled Drugs Part II or Part III.</div>
            <div class="choice-option">Computerized sales records do not need to be printable as long as they are accessible on screen.</div>
            <div class="choice-option">Sales records for benzodiazepines and targeted substances must be kept in a separate, dedicated register.</div>
            <div class="choice-option">All sales records for these substances must be submitted to the Office of Controlled Substances monthly.</div>
            <div class="choice-option">The patient's signature is required in the sales record for every narcotic dispensed.</div>
            <div class="choice-option">Only the quantity dispensed needs to be recorded, not the patient's name or prescriber details.</div>
            <div class="choice-option">Purchase records (invoices) can substitute for sales records if filed chronologically.</div>
            <div class="choice-option">Sales records only need to be kept for 1 year from the date of sale.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_009">
        <p class="question-text">What are two actions a pharmacist MUST take upon discovering a loss or theft of a narcotic substance in their Ontario pharmacy?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Report the loss or theft to the federal Office of Controlled Substances (Health Canada) within 10 days of its discovery.</div>
            <div class="choice-option" data-correct="true">Take all reasonable steps to protect narcotics on their premises or under their control against loss or theft (e.g., through secure storage, alarms).</div>
            <div class="choice-option">Only report the loss if the quantity exceeds a predetermined significant amount.</div>
            <div class="choice-option">Notify the Ontario College of Pharmacists (OCP) immediately, but reporting to Health Canada is optional.</div>
            <div class="choice-option">Wait for the next scheduled inventory count to confirm the loss before reporting.</div>
            <div class="choice-option">Report forgeries only if the forged prescription was actually filled and dispensed.</div>
            <div class="choice-option">The designated manager is solely responsible for reporting; staff pharmacists who discover the loss do not need to take further action.</div>
            <div class="choice-option">Document the loss internally but avoid external reporting to prevent negative scrutiny on the pharmacy.</div>
            <div class="choice-option">The 10-day reporting window starts from the date the narcotic was last accounted for, not from the date of discovery of the loss.</div>
            <div class="choice-option">Small spillages or breakages of narcotics do not count as losses and do not require reporting.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_010">
        <p class="question-text">When destroying narcotics or controlled drugs returned by patients or expired stock, which two procedures are generally required in Ontario?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">For narcotics and most controlled drugs, prior authorization for destruction must be obtained from Health Canada's Office of Controlled Substances.</div>
            <div class="choice-option" data-correct="true">The destruction process should alter and denature the drugs to render consumption improbable or impossible, and this is often witnessed by another pharmacist, technician, or practitioner.</div>
            <div class="choice-option">Benzodiazepines and targeted substances require the same prior authorization from Health Canada for destruction as narcotics.</div>
            <div class="choice-option">Returned patient medications can be immediately mixed with regular pharmacy waste for disposal.</div>
            <div class="choice-option">A record of destruction is only needed for narcotics, not for controlled drugs or targeted substances.</div>
            <div class="choice-option">The pharmacist can destroy these substances independently without a witness, as long as they document it.</div>
            <div class="choice-option">Authorization requests for destruction must only list the trade names, not quantities or strengths.</div>
            <div class="choice-option">Destroyed drugs should remain in the pharmacy's inventory records until the end of the fiscal year.</div>
            <div class="choice-option">Pharmacies must physically count and reconcile all controlled substances monthly to identify items for destruction.</div>
            <div class="choice-option">The OCP provides pre-approved forms for pharmacists to self-authorize destruction of small quantities of narcotics.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_011">
        <p class="question-text">Identify two key requirements for a pharmacy in Ontario that intends to dispense methadone for Maintenance Treatment (MMT) or pain management.</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The pharmacy must notify the Ontario College of Pharmacists (OCP) within 7 days of starting to dispense methadone and update the OCP on their status (e.g., accepting new patients, trained pharmacists).</div>
            <div class="choice-option" data-correct="true">The pharmacy must ensure that the designated manager and at least one staff pharmacist are appropriately trained in methadone dispensing (e.g., CAMH or OPA programs) within specified timeframes, with training updated every 5 years.</div>
            <div class="choice-option">Physicians prescribing methadone do not require any special exemption from Health Canada as long as they are licensed in Ontario.</div>
            <div class="choice-option">Methadone for MMT must always be dispensed undiluted to ensure accurate dosing by the patient at home.</div>
            <div class="choice-option">A written pharmacy-patient agreement for methadone treatment is a recommendation but not a mandatory component of OCP policy.</div>
            <div class="choice-option">Pharmacists can independently initiate methadone therapy for opioid dependence if a patient presents with withdrawal symptoms.</div>
            <div class="choice-option">Required reference materials for methadone (e.g., CAMH guidelines) are optional for pharmacies with experienced staff.</div>
            <div class="choice-option">Methadone prescriptions can be received verbally for both MMT and pain management.</div>
            <div class="choice-option">The OCP automatically grants methadone dispensing privileges to all newly accredited pharmacies.</div>
            <div class="choice-option">Daily reconciliation of methadone is only required if doses are transferred to an external treatment location, not for in-pharmacy dispensing.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_012">
        <p class="question-text">When preparing the final dosage form of methadone for MMT, which two practices are mandated by guidelines (e.g., CAMH)?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The daily dose of methadone must be diluted in approximately 100mL of a vehicle that does not lend itself to injection (e.g., an orange-flavoured drink like Tang).</div>
            <div class="choice-option" data-correct="true">Child-proof safety caps must be used on bottles containing methadone doses.</div>
            <div class="choice-option">Using a graduated cylinder is the recommended method for ensuring accurate dilution of methadone stock solution.</div>
            <div class="choice-option">The methadone dose should be dispensed in a clear, unflavored vehicle to allow for easy visual inspection by the patient.</div>
            <div class="choice-option">It is acceptable to dispense multiple days' doses in a single, larger bottle if the patient requests it for convenience.</div>
            <div class="choice-option">The label must include the exact time the dose was prepared.</div>
            <div class="choice-option">Using a measuring pump is discouraged due to potential inaccuracies with viscous methadone solutions.</div>
            <div class="choice-option">The warning "MAY BE FATAL TO CHILD OR ADULT" is only required if the dose exceeds 50mg.</div>
            <div class="choice-option">"Keep refrigerated" is an optional auxiliary label, depending on the chosen diluent.</div>
            <div class="choice-option">The pharmacist can choose not to dilute the methadone if they observe the patient ingesting the first dose.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_013">
        <p class="question-text">Under the Narcotic Safety and Awareness Act, 2010 (NSAA) in Ontario, what are two specific requirements for a dispenser (e.g., pharmacist) when dispensing a monitored drug?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The dispenser must ensure that identity verification requirements are met before dispensing a monitored drug and keep a record of the patient's identifying number and type of ID used.</div>
            <div class="choice-option" data-correct="true">If the person picking up the prescription is not the patient (i.e., an agent), the dispenser must record the name, address, identifying number, and type of ID of that agent.</div>
            <div class="choice-option">The prescriber's CPSO registration number must be verbally confirmed by the dispenser for every monitored drug prescription.</div>
            <div class="choice-option">The patient's original identification document must be photocopied and attached to the hard copy of the prescription.</div>
            <div class="choice-option">The NSAA only applies to narcotics listed in the CDSA, not other opioids like tramadol.</div>
            <div class="choice-option">If a patient does not have an approved form of ID, the pharmacist can use their professional judgment to waive the ID requirement.</div>
            <div class="choice-option">The patient's identifying number and type of ID must be written directly on the face of the original prescription by the dispenser.</div>
            <div class="choice-option">The NSAA requirements do not apply if the monitored drug is being dispensed as a part-fill.</div>
            <div class="choice-option">Only an Ontario Health Card is an acceptable form of ID under NSAA regulations.</div>
            <div class="choice-option">Dispensers are exempt from NSAA requirements if the prescription originates from a hospital setting.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_014">
        <p class="question-text">The NSAA regulations specify acceptable forms of patient identification for dispensing monitored drugs. Which two of the following are listed as approved forms of ID?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">A valid driver's license (from Ontario or another province/territory).</div>
            <div class="choice-option" data-correct="true">A valid passport (Canadian or from another country).</div>
            <div class="choice-option">A student identification card from a Canadian university.</div>
            <div class="choice-option">A credit card with a photo.</div>
            <div class="choice-option">An employee identification badge.</div>
            <div class="choice-option">A social insurance number (SIN) card.</div>
            <div class="choice-option">A library card with a photo.</div>
            <div class="choice-option">A letter of employment on company letterhead.</div>
            <div class="choice-option">A gym membership card.</div>
            <div class="choice-option">A digital photo of an ID stored on a smartphone.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_015">
        <p class="question-text">What are two key purposes of the Narcotic Safety and Awareness Act, 2010 (NSAA) in Ontario?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">To promote appropriate prescribing and dispensing practices for monitored drugs.</div>
            <div class="choice-option" data-correct="true">To identify, reduce, and prevent the abuse, misuse, and diversion of monitored drugs.</div>
            <div class="choice-option">To set the pricing for all opioid medications dispensed in the province.</div>
            <div class="choice-option">To mandate specific treatment protocols for patients with opioid addiction.</div>
            <div class="choice-option">To replace the federal Controlled Drugs and Substances Act within Ontario.</div>
            <div class="choice-option">To ensure all patients in Ontario receive opioid prescriptions free of charge.</div>
            <div class="choice-option">To restrict the prescribing of opioids to specialized pain clinics only.</div>
            <div class="choice-option">To collect data primarily for research purposes, not for direct intervention in prescribing or dispensing.</div>
            <div class="choice-option">To require all pharmacists to complete advanced pain management certification.</div>
            <div class="choice-option">To eliminate the need for prescriptions for certain low-dose opioids.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_016">
        <p class="question-text">Regarding advertising of narcotics in Ontario, which two statements are correct based on the regulations?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Direct or indirect advertising of the sale of a narcotic is not allowed.</div>
            <div class="choice-option" data-correct="true">Narcotics cannot be visibly displayed in the pharmacy; they must be hidden from public view.</div>
            <div class="choice-option">Pharmacies can advertise "low prices on all pain medications," including narcotics.</div>
            <div class="choice-option">Advertising is permitted if it only shows the chemical name of the narcotic, not the brand name.</div>
            <div class="choice-option">Exempted codeine preparations can be advertised as long as the codeine content is clearly stated.</div>
            <div class="choice-option">Pharmacies can display posters promoting the benefits of specific narcotic analgesics.</div>
            <div class="choice-option">The restriction on advertising only applies to print media, not online advertisements.</div>
            <div class="choice-option">It is acceptable to advertise a "special discount" on dispensing fees for narcotic prescriptions.</div>
            <div class="choice-option">The term "narcotic" can be used in advertising as long as no specific drug names are mentioned.</div>
            <div class="choice-option">Advertising restrictions do not apply to methadone used for MMT.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_017">
        <p class="question-text">Who can receive a verbal prescription for a "Verbal Prescription Narcotic" or a Controlled Drug (where verbal Rxs are permitted) in an Ontario pharmacy?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">A pharmacist registered with the OCP.</div>
            <div class="choice-option" data-correct="true">A registered pharmacy student acting under the direct supervision of a pharmacist who is physically present.</div>
            <div class="choice-option">Any pharmacy assistant who has worked in the pharmacy for over a year.</div>
            <div class="choice-option">A pharmacy technician, independently without direct pharmacist supervision.</div>
            <div class="choice-option">The pharmacy owner, even if they are not a registered pharmacist.</div>
            <div class="choice-option">A delivery driver employed by the pharmacy.</div>
            <div class="choice-option">A nurse working in an adjacent medical clinic.</div>
            <div class="choice-option">Only the designated manager of the pharmacy.</div>
            <div class="choice-option">A pharmacy intern, but only if the supervising pharmacist is not on the premises.</div>
            <div class="choice-option">A relative of the patient calling on their behalf.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_018">
        <p class="question-text">The text mentions "double doctoring" in relation to narcotics and controlled substances. Which two actions constitute "double doctoring" under the CDSA?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">A person seeking or obtaining a substance included in CDSA Schedules I, II, III, or IV from a practitioner without disclosing any prescriptions for such substances received from another practitioner within the previous 30 days.</div>
            <div class="choice-option" data-correct="true">A person seeking authorization (a prescription) from a practitioner for a substance in CDSA Schedules I, II, III, or IV without disclosing authorizations for such substances received from another practitioner within the previous 30 days.</div>
            <div class="choice-option">A patient seeing two different doctors for two unrelated medical conditions.</div>
            <div class="choice-option">A pharmacist calling a second doctor to verify a prescription written by a first doctor.</div>
            <div class="choice-option">A patient receiving prescriptions for two different narcotics from the same doctor for legitimate pain management.</div>
            <div class="choice-option">A doctor referring a patient to a specialist who then also prescribes medication.</div>
            <div class="choice-option">A patient refilling a legitimate prescription at two different pharmacies.</div>
            <div class="choice-option">Disclosing only some, but not all, relevant prescriptions from the last 30 days to a new practitioner.</div>
            <div class="choice-option">Asking a practitioner for a higher dose of a previously prescribed narcotic.</div>
            <div class="choice-option">A practitioner prescribing a narcotic and a benzodiazepine to the same patient concurrently.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_019">
        <p class="question-text">What are two specific requirements for the labeling of methadone dispensed for MMT, in addition to standard DPRA labeling requirements?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The total milligram dose of methadone in the bottle.</div>
            <div class="choice-option" data-correct="true">A warning such as "Methadone may cause serious harm... MAY BE FATAL TO CHILD OR ADULT."</div>
            <div class="choice-option">The name of the specific CAMH guideline used for dilution.</div>
            <div class="choice-option">The patient's photo identification number.</div>
            <div class="choice-option">The exact time the dose is scheduled to be ingested.</div>
            <div class="choice-option">A "Shake Well Before Use" auxiliary label.</div>
            <div class="choice-option">The lot number of the diluent (e.g., Tang) used.</div>
            <div class="choice-option">The signature of the pharmacist who prepared the dose.</div>
            <div class="choice-option">A statement that the dose was prepared in a sterile environment.</div>
            <div class="choice-option">The expiry date of the methadone stock solution used.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_020">
        <p class="question-text">If a pharmacist receives a written prescription for a narcotic where the signature of the prescriber is not known to them, what are two appropriate actions to take?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The pharmacist must verify the signature to ensure authenticity before dispensing.</div>
            <div class="choice-option" data-correct="true">This verification is a reasonable step to protect against loss or theft through forgery, as required by regulations.</div>
            <div class="choice-option">The pharmacist can dispense the medication first and verify the signature later if they are busy.</div>
            <div class="choice-option">If the quantity is small, signature verification is not strictly necessary.</div>
            <div class="choice-option">The pharmacist should refuse to fill the prescription outright without attempting verification.</div>
            <div class="choice-option">Verification is only required if the patient appears suspicious.</div>
            <div class="choice-option">A pharmacy technician can perform the signature verification if the pharmacist is unavailable.</div>
            <div class="choice-option">The pharmacist can accept a faxed copy of the prescriber's signature from their office as sufficient verification.</div>
            <div class="choice-option">As long as the prescriber's CPSO number is on the prescription, signature verification is optional.</div>
            <div class="choice-option">The pharmacist should dispense the drug but report the unknown signature to the OCP afterwards.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_021">
        <p class="question-text">What are two acceptable methods for a pharmacist to order controlled substances (e.g., Part I Controlled Drugs) from a licensed dealer in Canada?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">By a written order signed by an authorized pharmacist ("Narcotic Signer").</div>
            <div class="choice-option" data-correct="true">Through a computer from a remote input device, provided the licensed dealer receives a signed receipt from the pharmacist within 5 working days.</div>
            <div class="choice-option">By a verbal order over the phone for any type of controlled substance, as long as it's documented internally.</div>
            <div class="choice-option">By sending an email request from the pharmacy's general email account.</div>
            <div class="choice-option">A pharmacy technician can place orders for controlled substances if the pharmacist provides verbal authorization.</div>
            <div class="choice-option">Orders can be placed by faxing a copy of a patient's prescription that requires the controlled substance.</div>
            <div class="choice-option">Through a mobile app provided by the licensed dealer, without requiring a signed receipt.</div>
            <div class="choice-option">By using a pre-signed blank order form kept securely in the pharmacy.</div>
            <div class="choice-option">Only the designated manager of the pharmacy is authorized to sign orders for controlled substances.</div>
            <div class="choice-option">Verbal orders for controlled substances are permitted if followed by a written confirmation within 30 days.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_022">
        <p class="question-text">The Narcotic Control Regulations require specific information to be recorded upon receipt of a narcotic or controlled drug from a supplier. Which two pieces of information must the pharmacist enter into their purchase record (e.g., register or invoice file)?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The name and quantity of the drug received.</div>
            <div class="choice-option" data-correct="true">The date the drug was received and the name and address of the supplier.</div>
            <div class="choice-option">The signature of the delivery driver who brought the order.</div>
            <div class="choice-option">The expiry date of each product received.</div>
            <div class="choice-option">The cost price of the drug to the pharmacy.</div>
            <div class="choice-option">The lot number of each narcotic product received.</div>
            <div class="choice-option">The name of the pharmacy technician who unpacked the order.</div>
            <div class="choice-option">The time of day the shipment was delivered.</div>
            <div class="choice-option">The temperature of the shipping container upon arrival.</div>
            <div class="choice-option">A copy of the licensed dealer's own inventory record for the shipment.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_023">
        <p class="question-text">If a prescriber writes a prescription for a narcotic specifically for their "office use" or "personal use," how must a pharmacist handle this according to Narcotic Control Regulations?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">This transaction must be recorded in the pharmacy's sales report for narcotics.</div>
            <div class="choice-option" data-correct="true">This can be done, but it's not treated like a regular patient prescription for dispensing records (it's a sale to a practitioner).</div>
            <div class="choice-option">Pharmacists are strictly prohibited from supplying narcotics to prescribers for office or personal use.</div>
            <div class="choice-option">The prescriber must obtain a special "office use" license from Health Canada before a pharmacy can supply them.</div>
            <div class="choice-option">Such supplies are exempt from all record-keeping requirements.</div>
            <div class="choice-option">The quantity supplied for office use is limited to a 7-day supply per practitioner per month.</div>
            <div class="choice-option">This type of supply does not require a written order from the practitioner.</div>
            <div class="choice-option">The pharmacist must report all such supplies directly to the prescriber's regulatory college (e.g., CPSO).</div>
            <div class="choice-option">Only verbal prescription narcotics can be supplied for office use.</div>
            <div class="choice-option">The pharmacist must witness the practitioner administer the narcotic if it's for personal use.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_024">
        <p class="question-text">What are two requirements for maintaining the special narcotic prescription file in an Ontario pharmacy?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Prescriptions for narcotics must be filed in sequence as to date and prescription number.</div>
            <div class="choice-option" data-correct="true">This special narcotic prescription file must be maintained for a minimum of two years.</div>
            <div class="choice-option">Prescriptions for controlled drugs must be filed separately from narcotic prescriptions.</div>
            <div class="choice-option">Only original written prescriptions are kept in this file; records of verbal narcotics are stored elsewhere.</div>
            <div class="choice-option">This file must be submitted to Health Canada for auditing every six months.</div>
            <div class="choice-option">The file should be organized alphabetically by patient last name.</div>
            <div class="choice-option">Prescriptions for benzodiazepines and targeted substances are also included in this special narcotic file.</div>
            <div class="choice-option">After two years, the prescriptions in this file can be discarded without further retention requirements.</div>
            <div class="choice-option">A digital scan of the narcotic prescription is sufficient; the hard copy does not need to be filed this way.</div>
            <div class="choice-option">This file must be stored in a locked safe, separate from other pharmacy records.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_025">
        <p class="question-text">The Narcotic Safety and Awareness Act (NSAA) has specific exemptions for its requirements in certain settings. Which two settings are mentioned as potentially exempting prescribers from some NSAA requirements?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Hospitals</div>
            <div class="choice-option" data-correct="true">Prisons (correctional facilities)</div>
            <div class="choice-option">Private dental clinics</div>
            <div class="choice-option">Community pharmacies</div>
            <div class="choice-option">Long-term care homes</div>
            <div class="choice-option">Walk-in medical clinics</div>
            <div class="choice-option">Veterinary clinics</div>
            <div class="choice-option">University student health centers</div>
            <div class="choice-option">Methadone maintenance treatment clinics (specifically for ID requirements)</div>
            <div class="choice-option">Telemedicine consultations originating from a patient's home.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_026">
        <p class="question-text">Under NSAA Section 7, if a patient does not have appropriate identification when a prescription for a monitored drug is presented, what are two conditions or allowances mentioned regarding dispensing?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">Exemptions may be provided to allow the prescription to be prescribed/dispensed if the patient does not have appropriate identification.</div>
            <div class="choice-option" data-correct="true">If dispensed under such an exemption, only the patient themselves can pick up or accept a delivery of the medication; an agent cannot.</div>
            <div class="choice-option">The pharmacist must refuse to dispense the medication under all circumstances if ID is not presented.</div>
            <div class="choice-option">The pharmacist can accept a verbal confirmation of identity from the prescriber's office in lieu of patient ID.</div>
            <div class="choice-option">A family member can present their own ID to pick up the medication for the patient.</div>
            <div class="choice-option">The pharmacist can dispense a 3-day emergency supply, with the remainder to be picked up once ID is available.</div>
            <div class="choice-option">The requirement for ID is waived if the prescription is for a child under 16.</div>
            <div class="choice-option">The pharmacist must document the lack of ID and report it to the Ministry of Health.</div>
            <div class="choice-option">A photograph of the patient taken by the pharmacy staff can serve as temporary ID.</div>
            <div class="choice-option">The NSAA allows for a "known patient" exemption where regulars do not need to show ID.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_027">
        <p class="question-text">What are two key details a pharmacist must document when transferring custody of methadone doses to a physician or their delegate at a treatment location?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The physician or delegate must sign a patient manifest daily to confirm receipt of the correct dose(s).</div>
            <div class="choice-option" data-correct="true">The method of transportation used for the doses must be trackable to ensure safekeeping if not directly handed over.</div>
            <div class="choice-option">The pharmacist must obtain a new prescription from the physician for each daily transfer.</div>
            <div class="choice-option">The delegate receiving the doses must be a registered nurse or another pharmacist.</div>
            <div class="choice-option">A photograph of the person receiving the doses must be taken daily.</div>
            <div class="choice-option">The pharmacist must personally deliver all transferred doses and observe ingestion at the treatment location.</div>
            <div class="choice-option">The patient manifest only needs to be signed weekly by the physician.</div>
            <div class="choice-option">The exact temperature of the methadone doses at the time of transfer must be recorded.</div>
            <div class="choice-option">The OCP must be notified daily of all methadone transfers.</div>
            <div class="choice-option">The receiving physician or delegate must provide a written inventory of their current methadone stock to the pharmacist.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_028">
        <p class="question-text">If there are changes in a patient's methadone dosing for MMT, or if unused doses are returned from a treatment location, what are two correct procedures?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">A new prescription is required from the exempted prescriber each time there is a change in the methadone dose.</div>
            <div class="choice-option" data-correct="true">Unused individually labelled doses of methadone returned to the pharmacy by the physician or delegate should be signed for upon receipt, entered into appropriate records, and then destroyed in accordance with laws and policies.</div>
            <div class="choice-option">Pharmacists can verbally adjust methadone doses based on communication with the treatment clinic without a new prescription.</div>
            <div class="choice-option">Returned unused methadone doses can be re-dispensed to other MMT patients if they are unopened and properly stored.</div>
            <div class="choice-option">Changes in dosing only require a new prescription if the dose is being increased, not decreased.</div>
            <div class="choice-option">Unused doses should be returned to the licensed dealer, not the dispensing pharmacy.</div>
            <div class="choice-option">The physician or delegate can destroy unused doses at the treatment location without returning them to the pharmacy.</div>
            <div class="choice-option">A daily reconciliation of returned doses is recommended but not mandatory.</div>
            <div class="choice-option">If a dose is missed by the patient, that specific labelled dose can be used for the next day's administration.</div>
            <div class="choice-option">Minor dose adjustments (e.g., +/- 5mg) do not require a new prescription if within a physician-approved titration range.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_029">
        <p class="question-text">The Narcotic Control Regulations allow a pharmacist to supply another pharmacist with a quantity of a narcotic for "emergency purposes." Which two conditions apply to this type of supply?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">The supply is typically limited to an amount sufficient to fill one emergency prescription.</div>
            <div class="choice-option" data-correct="true">The requesting pharmacist must provide a written order, signed and dated, to the supplying pharmacist.</div>
            <div class="choice-option">This emergency supply can be for any narcotic, including straight narcotics and verbal prescription narcotics.</div>
            <div class="choice-option">No documentation is required for such emergency transfers between pharmacies.</div>
            <div class="choice-option">The supplying pharmacist can use a patient's prescription as the order for this transfer.</div>
            <div class="choice-option">This provision allows for routine stock balancing between pharmacies.</div>
            <div class="choice-option">The receiving pharmacist does not need to record this as a purchase.</div>
            <div class="choice-option">A verbal request is sufficient in an emergency, with written follow-up within 24 hours.</div>
            <div class="choice-option">The "emergency purpose" is defined as any situation where a pharmacy is low on stock.</div>
            <div class="choice-option">This type of supply is exempt from being recorded in the sales records of the supplying pharmacy.</div>
        </div>
    </div>

    <div class="question-item" data-id="jp_b_030">
        <p class="question-text">What are two key aspects of the definition or requirements for a "prescription" for a narcotic or controlled drug, as outlined in the provided text?</p>
        <div class="choices">
            <div class="choice-option" data-correct="true">It is a direction given by a practitioner that a stated amount of the narcotic (or controlled drug) be dispensed for the person named.</div>
            <div class="choice-option" data-correct="true">The quantity to be dispensed must be clearly stated on the prescription or be easily calculable from the directions (e.g., "1 tablet TID for 7 days" is acceptable, but "1 tablet TID PRN for 7 days" is not for quantity calculation).</div>
            <div class="choice-option">A prescription for a narcotic can be valid even if it does not name a specific patient (e.g., "for office stock").</div>
            <div class="choice-option">The directions for use are optional if the patient has used the medication before.</div>
            <div class="choice-option">A pharmacist can infer the quantity if only "dispense #30 PRN" is written.</div>
            <div class="choice-option">The prescription must always specify the brand name of the narcotic or controlled drug, not just the generic name.</div>
            <div class="choice-option">A verbal order for a straight narcotic is considered a valid prescription if documented correctly.</div>
            <div class="choice-option">The prescription must include the patient's diagnosis.</div>
            <div class="choice-option">A prescription for a controlled drug is valid indefinitely until all refills are used.</div>
            <div class="choice-option">The prescriber's signature can be a rubber stamp if their registration number is also present.</div>
        </div>
    </div>

</div>
